Press Release

Medtronic Announces 8 Percent Increase in Cash Dividend

42nd  Consecutive Year of Dividend Increases

DUBLIN – June 21, 2019 – The board of directors of Medtronic plc (NYSE:MDT) today approved  an 8 percent increase in its quarterly cash dividend, raising the quarterly  amount to $0.54 per ordinary share. This would translate into an annual amount  of $2.16 per ordinary share, or a dividend per share payout ratio of 41 percent  of prior fiscal year non-GAAP diluted earnings per share (EPS). Today's  announcement marks the 42nd consecutive year of an increase in the dividend  payment for Medtronic, a constituent of the S&P 500 Dividend Aristocrats  index. Including today's increase, Medtronic's dividend per share has grown by 77  percent over the past 5 years and has grown at a 17 percent compounded annual  growth rate over the past 42 years.

"Medtronic's strong and  growing dividend is an important component of the total return we expect to deliver  to our shareholders," said Omar Ishrak, Medtronic chairman and chief  executive officer. "Our board and management team have great confidence in  Medtronic's ability to generate significant cash flow, and we expect to balance  the deployment of this capital through both disciplined investments to drive  future growth and returning cash to shareholders."

Medtronic has a strong track record  of returning capital to its shareholders, including returning $4.6 billion in  fiscal year 2019. The company remains committed to returning a minimum of 50  percent of its free cash flow to shareholders through dividends and share  repurchases. Medtronic continues to expect to grow its dividend in line with  earnings, and it is focused on maintaining a payout ratio on prior fiscal year  non-GAAP EPS around 40 percent. The dividend is payable on July 25, 2019, to  shareholders of record at the close of business on July 8, 2019.

About Medtronic
Medtronic plc (, headquartered in Dublin, Ireland, is among the world's largest  medical technology, services and solutions companies – alleviating pain,  restoring health and extending life for millions of people around the world.  Medtronic employs more than 90,000 people worldwide, serving physicians,  hospitals and patients in more than 150 countries. The company is focused on  collaborating with stakeholders around the world to take healthcare Further,  Together.

Any  forward-looking statements are subject to risks and uncertainties such as those  described in Medtronic's periodic reports on file with the Securities and  Exchange Commission. Actual results may differ materially from anticipated  results.


  Francesca DeMartino
  Public Relations
  Ryan Weispfenning
  Investor Relations